Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Debt / NOTE 2.000% 8/1
-
Market price (% of par)
-
75.3%
-
Total 13F principal
-
$291,967,500
-
Principal change
-
+$259,033,500
-
Total reported market value
-
$220,710,621
-
Number of holders
-
29
-
Value change
-
+$196,009,621
-
Number of buys
-
28
Institutional Holders of AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 as of Q3 2015
As of 30 Sep 2015 AEGERION PHARMACEUTICALS INC - NOTE 2.000% 8/1 had 29 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $291,967,500 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, WOLVERINE ASSET MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, Allianz Asset Management AG, BAKER BROS. ADVISORS LP, CITADEL ADVISORS LLC, ZAZOVE ASSOCIATES LLC, UBS OCONNOR LLC, PUTNAM INVESTMENTS LLC, and CITIGROUP INC.
This table shows 29 bond principal holders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.